Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$109.4M
+38.4% from 2023
Prescriptions
5,854
$18,685.71 per claim
Patients
3,446
2,322 prescribers
Total spending, 2024
$109.4M
$31,736.86 per patient
Medicare prescription drug plans paid $109.4M for Invega Hafyera in 2024, for 5,854 prescriptions and refills to 3,446 patients (up 38.4% from 2023). The average cost per claim was $18,685.71.
California had the highest Medicare cost for Invega Hafyera in 2024: $16.8M for 863 claims, followed by Texas ($10.0M).
John W Allen, psychiatry in El Cajon, CA, had the highest Medicare cost for Invega Hafyera in 2024: 73 claims costing $1.6M.
Invega Hafyera is made by Johnson & Johnson (JNJ), listed in the Medicare spending data as Janssen Pharm..
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| John W Allen El Cajon, CA | Psychiatry | 73 | 41 | $1.6M |
| Arvind K Mathur Hemet, CA | Internal Medicine | 36 | 19 | $748K |
| Francis R Tan Las Vegas, NV |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 1,030 | 2,388 | 1,581 | $40.9M |
| 2023 | 1,811 | 4,294 | 2,762 | $79.0M |
| 2024 | 2,322 | 5,854 | 3,446 | $109.4M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Family Practice |
| 34 |
| 18 |
| $731K |
| Jacob B Chennat Irving, TX | Pharmacist | 33 | 33 | $684K |
| Alok C Saxena Las Vegas, NV | Internal Medicine | 29 | 17 | $617K |
| Bert A Hartman Madison, TN | Psychiatry | 29 | 14 | $539K |
| Yuliya Spencer Birmingham, AL | Nurse Practitioner | 27 | 13 | $538K |
| Peter N Mattar Fontana, CA | Family Practice | 25 | 16 | $521K |
| Kamel L Kamel Irvine, CA | Psychiatry | 25 | 21 | $519K |
| Sanjeev B Rao Saint Louis, MO | Psychiatry | 30 | 17 | $499K |
| Patricia D Salvato Houston, TX | Internal Medicine | 23 | 12 | $480K |
| Douglas H Phan Riverside, CA | Psychiatry & Neurology | 23 | 16 | $466K |
| Ajmal Mohammad Lawndale, CA | Nurse Practitioner | 22 | 11 | $459K |
| Khoa D Le Las Vegas, NV | Internal Medicine | 21 | 15 | $453K |
| Jonathan Wirjo Las Vegas, NV | Psychiatry | 20 | 12 | $421K |
| Ronald J Philipp Long Beach, CA | Family Practice | 20 | 11 | $378K |
| Robert N Berthold Lawndale, CA | Psychiatry | 18 | Under 11 | $358K |
| Alexandra Smith Tyler, TX | Physician Assistant | 16 | Under 11 | $332K |
| Emily M Freimuth Blue Ash, OH | Nurse Practitioner | 17 | Under 11 | $331K |
| Cynthia Recinto Wildomar, CA | Internal Medicine | 16 | Under 11 | $326K |
| Mark B Morman Beaumont, TX | Psychiatry | 15 | Under 11 | $305K |
| Xiaofan Li Houston, TX | Psychiatry | 16 | Under 11 | $304K |
| Marcel S Filart Los Angeles, CA | Geriatric Medicine | 14 | Under 11 | $299K |
| Leroy C Bell Jr. Baltimore, MD | Psychiatry | 15 | Under 11 | $267K |
| Craig Iannotti Manchester, NH | Nurse Practitioner | 12 | Under 11 | $260K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Janssen Pharm. JNJ | 5,856 | $109.4M |